Build with KISHO Sign In Sign Up

Kisho

Iovance Biotherapeutics, Inc — Rare Disease Pipeline | Kisho | Kisho

Iovance Biotherapeutics, Inc

Other

5

Orphan Designations

1

FDA Approvals

18

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
MPDU1-congenital disorder of glycosylation	Amtagvi	Orphan Designation	-
Wolf-Hirschhorn syndrome	Aldesleukin	Orphan Designation	-
adult neuronal ceroid lipofuscinosis	Amtagvi	Orphan Designation	-
adult pleomorphic rhabdomyosarcoma	Amtagvi	Orphan Designation	-
adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia	Amtagvi	Orphan Designation	-
amyotrophic lateral sclerosis	Aldesleukin	Orphan Designation	-
cancer-associated retinopathy	Amtagvi	Orphan Designation	-
cerebellar dysfunction with variable cognitive and behavioral abnormalities	autologous tumor infiltrating lymphocytes (TIL)	Orphan Designation	-
cutaneous melanoma	Amtagvi	Orphan Designation	-
double nail for fifth toe	Aldesleukin	Orphan Designation	-
familial papillary thyroid carcinoma with renal papillary neoplasia	autologous tumor infiltrating lymphocytes (TIL)	Orphan Designation	-
inborn error of immunity	Aldesleukin	Orphan Designation	-
malignant carotid body paraganglioma	Aldesleukin	Orphan Designation	-
malignant cornea melanoma	Amtagvi	Orphan Designation	-
malignant melanoma of the mucosa	Amtagvi	Orphan Designation	-
primary adult heart tumor	Amtagvi	Orphan Designation	-
rectum malignant melanoma	Amtagvi	Orphan Designation	-
uterine cervix carcinoma in situ	autologous tumor infiltrating lymphocytes (TIL)	Orphan Designation	-

← Back to Companies